# FDA Inspection 1210911 - Biogen International GmbH - June 16, 2023

Source: https://www.keypedia.com/records/fda_inspections/biogen-international-gmbh/d019071c-9f34-418b-9943-1e3c8133e4f9
Source feed: FDA_Inspections

> FDA Inspection 1210911 for Biogen International GmbH on June 16, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1210911
- Company Name: Biogen International GmbH
- Inspection Date: 2023-06-16
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1296612 - 2025-10-09](https://www.keypedia.com/records/fda_inspections/biogen-international-gmbh/45fb952b-b058-4cba-bef5-5d70815817b4)

Company: https://www.keypedia.com/companies/biogen-international-gmbh/204a24e4-d346-4dc4-b78a-ed40c3085d13

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c